| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Common Stock | Options Exercise | $884K | +73K | +12.85% | $12.12* | 641K | 15 Nov 2021 | Direct | F1 |
| transaction | MRVL | Common Stock | Options Exercise | $405K | +26K | +4.06% | $15.59* | 667K | 15 Nov 2021 | Direct | |
| transaction | MRVL | Common Stock | Options Exercise | $405K | +26K | +3.9% | $15.59* | 693K | 15 Nov 2021 | Direct | |
| transaction | MRVL | Common Stock | Sale | -$3.82M | -52.8K | -7.62% | $72.34 | 640K | 15 Nov 2021 | Direct | F2, F3 |
| transaction | MRVL | Common Stock | Sale | -$3.22M | -44.2K | -6.91% | $72.80 | 596K | 15 Nov 2021 | Direct | F2, F4 |
| transaction | MRVL | Common Stock | Sale | -$222K | -3.01K | -0.51% | $73.63 | 593K | 15 Nov 2021 | Direct | F2, F5 |
| transaction | MRVL | Common Stock | Sale | -$5M | -69.1K | -11.66% | $72.35 | 524K | 15 Nov 2021 | Direct | F2, F6 |
| transaction | MRVL | Common Stock | Sale | -$3.81M | -52.3K | -9.99% | $72.82 | 471K | 15 Nov 2021 | Direct | F2, F7 |
| transaction | MRVL | Common Stock | Sale | -$264K | -3.59K | -0.76% | $73.63 | 468K | 15 Nov 2021 | Direct | F2, F8 |
| transaction | MRVL | Common Stock | Sale | -$7.23M | -100K | -21.38% | $72.33 | 368K | 16 Nov 2021 | Direct | F2, F9 |
| holding | MRVL | Common Stock | 88.1K | 15 Nov 2021 | By Family Trusts | F10 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Non-Qualified Stock Option | Options Exercise | $0 | -73K | -100% | $0.00* | 0 | 15 Nov 2021 | Common Stock | 73K | $12.12 | Direct | F11, F12 |
| transaction | MRVL | Non-Qualified Stock Option | Options Exercise | $0 | -26K | -100% | $0.00* | 0 | 15 Nov 2021 | Common Stock | 26K | $15.59 | Direct | F11, F12 |
| transaction | MRVL | Non-Qualified Stock Option | Options Exercise | $0 | -26K | -100% | $0.00* | 0 | 15 Nov 2021 | Common Stock | 26K | $15.59 | Direct | F11, F13 |
| Id | Content |
|---|---|
| F1 | Starting share total was incorrectly reported on previous 11.17.2021 filing due to a clerical error. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.56 to $72.56, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.57 to $73.58, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F5 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.68, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F6 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.58 to $72.58, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F7 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.59 to $73.59, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F8 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.59 to $73.65, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F9 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.01 to $72.79, inclusive. The reporting person undertakes to provide Marvell, any security holder of Marvell, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F10 | Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family. |
| F11 | The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person. |
| F12 | The stock options completely vested on 11/01/2018. |
| F13 | The stock options completely vested on 02/16/2019. |
Raghib Hussain by Blair Walters as Attorney-In-Fact